JD Supra

Express Scripts Adds Biosimilar SEMGLEE to Preferred Formulary

In October, Express Scripts announced that it would add Viatris’ SEMGLEE (insulin glargine-yfgn) injection as a preferred therapy on its formulary beginning in January 2022. Back in July, the FDA ...
FierceHealthcare

Express Scripts to add Humira biosimilars to formulary as preferred products

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...
Yahoo Finance

Accord BioPharma's HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies

RALEIGH, N.C., Jan. 5, 2026 /PRNewswire/ -- Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care ...
FierceHealthcare

Express Scripts puts insulin biosimilar Semglee on preferred formulary

Express Scripts will prefer the first Food and Drug Administration-approved interchangeable biosimilar product, a move it says will lead to millions in savings. Semglee, which was developed by Viatris ...